BE735287A - - Google Patents

Info

Publication number
BE735287A
BE735287A BE735287DA BE735287A BE 735287 A BE735287 A BE 735287A BE 735287D A BE735287D A BE 735287DA BE 735287 A BE735287 A BE 735287A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE735287A publication Critical patent/BE735287A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE735287D 1968-06-27 1969-06-27 BE735287A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770731 DE1770731A1 (de) 1968-06-27 1968-06-27 Neue blutzuckersenkende Sulfonamide

Publications (1)

Publication Number Publication Date
BE735287A true BE735287A (enExample) 1969-12-29

Family

ID=5700618

Family Applications (1)

Application Number Title Priority Date Filing Date
BE735287D BE735287A (enExample) 1968-06-27 1969-06-27

Country Status (14)

Country Link
AT (3) AT291255B (enExample)
BE (1) BE735287A (enExample)
BR (1) BR6908777D0 (enExample)
CH (1) CH518968A (enExample)
DE (1) DE1770731A1 (enExample)
DK (1) DK123602B (enExample)
ES (1) ES368100A1 (enExample)
FR (1) FR2014300B1 (enExample)
GB (1) GB1268835A (enExample)
IE (1) IE33175B1 (enExample)
IL (1) IL32396A (enExample)
NL (1) NL6909960A (enExample)
NO (1) NO124374B (enExample)
SE (1) SE357365B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2048906A1 (de) * 1970-10-06 1972-04-13 Boehringer Mannheim Gmbh, 6800 Mannheim Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
EP1521577A1 (en) * 2002-06-13 2005-04-13 QLT, Inc. Methods of using isothiazole derivatives to treat cancer or inflammation

Also Published As

Publication number Publication date
IL32396A0 (en) 1969-08-27
ES368100A1 (es) 1971-05-01
NO124374B (enExample) 1972-04-10
FR2014300B1 (enExample) 1973-01-12
IE33175L (en) 1969-12-27
SE357365B (enExample) 1973-06-25
AT291255B (de) 1971-07-12
AT291256B (de) 1971-07-12
CH518968A (de) 1972-02-15
AT289109B (de) 1971-04-13
BR6908777D0 (pt) 1973-01-23
DK123602B (da) 1972-07-10
DE1770731A1 (de) 1971-11-25
GB1268835A (en) 1972-03-29
NL6909960A (enExample) 1969-12-30
FR2014300A1 (enExample) 1970-04-17
IE33175B1 (en) 1974-04-03
IL32396A (en) 1972-06-28

Similar Documents

Publication Publication Date Title
AU5506869A (enExample)
AU2374870A (enExample)
AU5184069A (enExample)
AU6168869A (enExample)
AU6171569A (enExample)
AU416157B2 (enExample)
FR2014300B1 (enExample)
AU429879B2 (enExample)
AU2581067A (enExample)
AU4811568A (enExample)
AU421558B1 (enExample)
AU3224368A (enExample)
AR203075Q (enExample)
AU3789668A (enExample)
AU2580267A (enExample)
BE725804A (enExample)
BE709320A (enExample)
BE709095A (enExample)
BE642636A (enExample)
BE723499A (enExample)
AU4558658A (enExample)
BE728675A (enExample)
BE709435A (enExample)
AU2496167A (enExample)
AU5758767A (enExample)